Trial comparisons

curl "https://conductscience.org/api/comparisons/v1?page=189"

Response

The first 2 of this page's 20 results. GET /api/comparisons/v1?page=189

{
  "data": {
    "total": 85013,
    "results": [
      {
        "id": "NCT01610414-137b3fed",
        "title": "GSK1437173A Group vs Placebo Group: Number of Subjects With Any Relapse",
        "summary": "239 of 922 against 253 of 924; risk difference -1.5 points, 95% interval -5.5 to 2.6; NCT01610414, Study to Evaluate Efficacy, Safety, and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Vaccine GSK1437173A",
        "record": "/library/comparisons/NCT01610414-137b3fed",
        "nct_id": "NCT01610414",
        "kind": "outcome",
        "participants": 1846,
        "risk_difference": {
          "value": -0.014590434872430558,
          "lower": -0.054852742676134054,
          "upper": 0.0257380528554206
        },
        "group_1": "239 of 922",
        "group_2": "253 of 924",
        "difference": "-1.5 points",
        "interval": "-5.5 to 2.6",
        "trial_title": "Study to Evaluate Efficacy, Safety, and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Vaccine GSK1437173A"
      },
      {
        "id": "NCT01610414-deaths",
        "title": "GSK1437173A Group vs Placebo Group: deaths from any cause",
        "summary": "118 of 922 against 124 of 924; risk difference -0.6 points, 95% interval -3.7 to 2.5; NCT01610414, Study to Evaluate Efficacy, Safety, and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Vaccine GSK1437173A",
        "record": "/library/comparisons/NCT01610414-deaths",
        "nct_id": "NCT01610414",
        "kind": "deaths",
        "participants": 1846,
        "risk_difference": {
          "value": -0.006216487778309909,
          "lower": -0.037094499966359454,
          "upper": 0.0246618220861712
        },
        "group_1": "118 of 922",
        "group_2": "124 of 924",
        "difference": "-0.6 points",
        "interval": "-3.7 to 2.5",
        "trial_title": "Study to Evaluate Efficacy, Safety, and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Vaccine GSK1437173A"
      }
    ],
    "no_events": 33758,
    "columns": [
      {
        "key": "title",
        "label": "Comparison"
      },
      {
        "key": "group_1",
        "label": "With the outcome",
        "under": "group_2"
      },
      {
        "key": "difference",
        "label": "Risk difference, 95% interval",
        "under": "interval"
      },
      {
        "key": "participants",
        "label": "Participants"
      },
      {
        "key": "nct_id",
        "label": "Trial",
        "under": "trial_title"
      }
    ],
    "order": "Most participants first",
    "kinds": {
      "all": 85013,
      "outcome": 33568,
      "serious-adverse-events": 31897,
      "deaths": 19548
    }
  },
  "release": "trial-comparisons-2026-03-23-0.1.0",
  "terms": [
    {
      "source": "ClinicalTrials.gov's posted results, through CTTI's AACT",
      "license": "ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299",
      "notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
      "short": "Freely available. Acknowledgement requested"
    },
    {
      "source": "ClinicalTrials.gov",
      "license": "none stated",
      "notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
      "short": "No license stated"
    }
  ],
  "next": "/api/comparisons/v1?page=190",
  "request_id": "B1KDYZFUpHsj4g43"
}